The nation of Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (£272m) over five years because of Washington's demand for confidential biological samples.
The decision came to light following a official document dated December was leaked, which showed President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesperson has since clarified that the US was requesting biological samples for scientific study and profit but was not willing to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further negotiations to reach a deal acceptable to all parties so the country's critical HIV programme can proceed.
Wider Context
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.
Based on reports, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information indefinitely, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"Put simply, our country would supply the basic resources for medical research with no assurance that the final treatments would be accessible to our people should a new pandemic arise."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were disrupting systems already established via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.
"This framework is intended to ensure that when a country contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."
These objections over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage further discussions with our American counterparts on how future co-operation could be designed in a way that honours the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks need to persist given that much of the nation's HIV programmes depended on international support.
"In cases where specific concerns exist, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," the group added.
The situation highlights the ongoing debate between accepting vital foreign assistance and protecting a country's data in an increasingly data-driven world.